NovoCure Limited (NVCR:NASDAQ) closed at $11.30 on November 16, 2026, down 4.48% on the day. The stock trades 47.3% below its 52-week high of $21.45 and 15.1% above its 52-week low of $9.82. Over the past year, it gained 0.3%. NovoCure Limited is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 14, 2025, NVCR closed higher on 118 days (47%). Its best day was July 23, 2026 (+28.39%) and its worst was June 18, 2026 (-20.00%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 5 times.
NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.
Find more stocks like NVCR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.